Annexon Biosciences, Inc. ( ($ANNX) ) has released its Q4 earnings. Here is a breakdown of the information Annexon Biosciences, Inc. presented to ...

Pacira (($PCRX)) has held its Q4 earnings call. Read on for the main highlights of the call. Pacira BioSciences’ recent earnings call painted a ...

Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, Ratings reports. One investment ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...

Gorgas, President and CEO of Artelo Biosciences. “Notably, enrollment in our Phase 1 study of ART26.12, a Fatty Acid Binding Protein (FABP) inhibitor, has progressed rapidly and is expected to ...

Pacira BioSciences (NASDAQ:PCRX – Free Report) had its price target upped by HC Wainwright from $57.00 to $70.00 in a report ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates. Overall, the quarter showcased strong ...

Cytek will host a conference call to discuss its fourth quarter and year end 2024 financial results on Thursday, February 27, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A webcast of the ...

Feb. 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq ... “Cogent is preparing to report data from three bezuclastinib pivotal clinical trials this year,” said Andrew Robbins, ...

View original content to download multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-reports-fourth-quarter-and-fiscal-2024-financial-results ...

HARMONY BIOSCIENCES ($HRMY) posted quarterly earnings results on Tuesday, February 25th. The company reported earnings of $0.85 per share, beating estimates of $0.75 ...